Seropositivity of HBsAg, Anti-HBs, Anti-HCV and Anti-HIV in patients admitted to Siirt Training and Research Hospital

Abstract

ABSTRACT Objective: Viral hepatitis infections, including hepatitis B and C, and HIV represent an important public health problem worldwide. In this study, we aimed to investigate the seropositivity of HBsAg, Anti-HBs, Anti-HCV, and Anti-HIV in patients who applied to our hospital between 2019 and 2021. Methods: In this study, the frequency of HBsAg, Anti-HBs, total Anti-HCV and anti-HIV in patients admitted to our hospital between January-2019-January 2021 was evaluated retrospectively. Results: HBsAg positivity was determined as 3.28% in a total of 52420 patients. HBsAg positivity was found to be 4.12% (95%CI: 3.9-4.3) in males, whereas 2.67% (95%CI 2.56-2.78) in females. There was a statistically significant relationship between HBsAg positivity and gender and age (p<0.001). Anti-HBs level of 54.9% of the patients (95%CI: 44.6-45.6) was found to be sufficient for immunity (Anti-HBs >10 mIU / ml). While this rate was found to be 61.04% (95%CI: 60.5-61.5) in males, it was found to be 50.37% (95%CI: 50-50.7) in females. A significant relationship was found between Anti-HBs positivity and gender and age (p<0.001). General Anti-HCV positivity was found as 0.11% (95%CI: 0.09-1.01). There was significant relationship between age groups for anti-HCV positivity (p<0.001), whereas the relationship for gender was not significant (p=0.934). There was no statistically significant relationship between anti-HIV positivity and age (p=0.307) and gender (p=0.999). Anti-HIV positivity was determined as 0.3‰ (95%CI: 0.01-1.05). Conclusion: As a result, viral hepatitis is an important health problem around the world and for our city. Vaccination, infection control programs, and public education can reduce the risk of new infections. Anti-HIV positivity was found to be very low in our city.